Form 4: Thermo Fisher Scientific Director Acquires Phantom Stock Units

Sentiment:

SEC Form 4 Filing


Director Dion J. Weisler acquired 72.08 phantom stock units in Thermo Fisher Scientific through a deferred compensation plan.

Summary

  • Dion J. Weisler, a director at Thermo Fisher Scientific, acquired 72.08 phantom stock units on December 31, 2024.
  • These units were credited to his account under the company's Deferred Compensation Plan for Directors.
  • The units were valued at $520.23 each, based on the closing stock price at the end of the quarter.
  • The phantom stock units are convertible into common stock on a 1-for-1 basis.
  • The shares will be distributed as stock upon cessation of director service or a change of control.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns interests. There are no indications of negative sentiment.

Positives

  • The acquisition of phantom stock units aligns the director's interests with those of the shareholders.
  • The deferred compensation plan allows directors to accumulate company stock over time.

Industry Context

This is a standard practice for director compensation in publicly traded companies, aligning director interests with shareholder value.

Comparison to Industry Standards

  • Deferred compensation plans using phantom stock units are a common practice among large publicly traded companies like Thermo Fisher Scientific.
  • Many companies in the life sciences and healthcare sectors use similar methods to compensate their directors, such as Danaher Corporation and Agilent Technologies.
  • These plans are designed to incentivize long-term value creation and align the interests of directors with those of shareholders.

Stakeholder Impact

  • The acquisition of phantom stock units by a director is generally viewed positively by shareholders as it aligns the director's interests with the company's long-term performance.

Key Dates

DateDescription
12/31/2024Date of the phantom stock unit acquisition.
01/02/2025Date the form was signed.

Keywords

Thermo Fisher Scientific, phantom stock units, director, Dion J. Weisler, deferred compensation, stock acquisition, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.